Skin Cancers Revisited

Sun Blocked A new study examines non-melanoma skin cancers & HIV by Chael Needle In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...

Bathroom Reading

A newly approved anti-diarrheal agent seeks to counter side effects of HAART by Chael Needle Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for...

Monoclonal Antibodies

Stronger Punch? Monoclonal antibodies provide new hope for easier dosing by Jeannie Wraight With multi-drug, once-a-day therapies now available for use, the push for additional easier to...

TB Announced

A not-for-profit biotech helps energize the future of TB vaccine R&D by Chael Needle According to the World Health Organization, tuberculosis is the most common illness...

Alisson Sombredero, MD

Not So Complicated Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care by Chael Needle Alisson Sombredero, MD, is more than two months into her...

Listen with Care

Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients by Chael Needle Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...

Expanded Portfolio

A new study reports on the drug-drug interaction between pitavastatin and a common PI combo by Chael Needle Last year, A&U reported on a study that...

Mother’s Milk

Could breast milk possibly be protective against HIV? by Chael Needle The benefits of breastfeeding in resource-poor countries while mothers and infants are on differently tailored...

Preventative HIV Vaccine

Express Lane A Vaccine Candidate Seeks to Prevent—Not Just Control—HIV Infection by Chael Needle Preventative HIV vaccine research has taken another step. The candidate, a granulocyte-macrophage colony stimulating factor...

First Line

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...

LATEST POSTS

FDA Approves Truvada as PrEP for Adolescents

On May 18, 2018, Gilead Sciences, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada for use as...